KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.61 $7.24 Friday, 26th Apr 2024 AFMD stock ended at $5.03. This is 3.07% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.35% from a day low at $4.88 to a day high of $5.19.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Aug 17, 2022 $32.30 $32.45 $31.40 $31.60 81 765
Aug 16, 2022 $33.10 $33.40 $32.12 $32.60 120 307
Aug 15, 2022 $30.20 $33.60 $30.20 $33.20 133 764
Aug 12, 2022 $29.70 $31.25 $29.40 $30.50 95 862
Aug 11, 2022 $31.50 $33.85 $29.00 $30.10 159 637
Aug 10, 2022 $33.20 $33.75 $32.60 $33.10 126 983
Aug 09, 2022 $32.50 $32.70 $31.20 $32.40 56 808
Aug 08, 2022 $33.40 $34.00 $32.20 $32.80 73 775
Aug 05, 2022 $32.30 $33.20 $31.30 $33.00 66 047
Aug 04, 2022 $30.00 $32.70 $29.70 $32.70 155 655
Aug 03, 2022 $27.90 $30.70 $27.90 $29.70 77 884
Aug 02, 2022 $27.30 $28.70 $27.00 $27.60 44 298
Aug 01, 2022 $28.10 $28.90 $27.40 $27.50 68 558
Jul 29, 2022 $29.20 $29.20 $27.70 $28.30 63 675
Jul 28, 2022 $30.70 $30.70 $28.95 $29.50 45 614
Jul 27, 2022 $30.80 $30.80 $30.00 $30.60 39 143
Jul 26, 2022 $29.80 $30.60 $28.90 $30.30 41 257
Jul 25, 2022 $29.50 $29.90 $28.95 $29.90 35 239
Jul 22, 2022 $30.90 $30.90 $29.20 $29.60 59 713
Jul 21, 2022 $30.70 $31.50 $30.20 $31.00 80 990
Jul 20, 2022 $29.70 $31.60 $29.00 $30.90 74 564
Jul 19, 2022 $28.90 $30.25 $28.55 $29.70 52 223
Jul 18, 2022 $30.00 $30.15 $28.50 $28.60 58 330
Jul 15, 2022 $30.60 $30.60 $28.40 $29.10 54 625
Jul 14, 2022 $30.00 $30.20 $29.25 $29.70 61 030
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT